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Summary
The self-incompatibility response of crucifers is a barrier
to fertilization in which arrest of pollen tube development
is mediated by allele-specific interactions between polymor-
phic receptors and ligands encoded by the S-locus haplo-
type. Activation of stigma-expressed S-locus receptor
kinase (SRK) [1] by pollen coat-localized S-locus cysteine-
rich (SCR) ligand [2–5] and the resulting rejection of pollen
occurs only if receptor and ligand are encoded by the
same S haplotype [4, 6–8]. To identify residues within the
SRK extracellular domain (eSRK) that are required for its
ligand-selective activation, we assayed chimeric receptors
and receptor variants containing substitutions at polymor-
phic sites in Arabidopsis thaliana [9, 10]. We show that
only a small number of the w100 polymorphic residues in
eSRK are required for ligand-specific activation of self-
incompatibility in vivo. These essential residues occur in
two noncontiguous clusters located at equivalent positions
in the two variants tested. They also correspond to sites
showing elevated levels of substitutions in other SRKs, sug-
gesting that these residues could define self-incompatibility
specificity in most SRKs. The results demonstrate that the
majority of eSRK residues that show signals of positive
selection and previously surmised to function as specificity
determinants are not essential for specificity in the SRK-SCR
interaction.
Results and Discussion
To understand the basis of ligand-selective activation of SRK,
we focused on polymorphic residues in the eSRK, a region
subject to strong diversifying selection, with extraordinarily
high levels of polymorphisms that have persisted for long
periods [11–16]. Comparison of SRK alleles, which can number
over 50 in one species, has shown that their amino acid
sequences can diverge by as much as 35% inBrassica species
[1, 17] and 51% in A. lyrata [16]. Sequence alignments have
demonstrated that polymorphic residues, although scattered
over the length of the eSRK, are particularly prevalent in
several ‘‘hypervariable regions’’ [17, 18], in which nonsynony-
mous to synonymous substitution (Ka/Ks) ratios are signifi-
cantly greater than 1 [19] or elevated relative to the rest of
*Correspondence: jbn2@cornell.eduthe protein [20]. These ‘‘hypervariable regions’’ also contain
many of the residues having a high posterior probability of
being under selective pressure to change in physicochemical
property [21]. These features have suggested that hypervari-
ability in these regions is not due to relaxed constraint but
rather to diversifying selection, and that the variable residues
within these regions function as SI specificity determinants.
Swapping the Hypervariable Regions of eSRK
To test the hypothesis that SI specificity resides in the hyper-
variable (hv) regions, specifically hvI, hvII, and hvIII
(Figure 1A), we assayed eSRK chimeras in which a segment
encompassing these regions was swapped between different
SRK variants in transgenic plants of the A. thaliana C24 acces-
sion [9]. We first generated AtS1pr::eSRKx:AlSRKb fusions
(Figure 1A; N.A.B., K.G.D., P. Shah, A.A. McCulloch, M.E.N.,
and J.B.N., unpublished data; Supplemental Experimental
Procedures, available online) in which the stigma-specific
AtS1 promoter [22] drives expression of an SRK consisting of
the eSRK (minus the last 23 amino acids) from one SRK variant
(eSRKx) fused to the last 23 amino acids of AleSRKb, followed
by the AlSRKb transmembrane and kinase domains. The
hvI–hvIII region of an AtS1pr::eSRKx:AlSRKb fusion was then
replaced with the corresponding region from other SRK vari-
ants to generate eSRKx(y)x chimeras (Figure 1B; Supplemental
Data), where ‘‘x’’ and ‘‘y’’ correspond to the number or letter of
the SRK allele from which the various regions were derived, and
the central swapped hvI–hvIII region is indicated in paren-
theses (Figure 1B). For each chimera, several independent
transgenic plants were assayed by pollinating stigmas
with transgenic A. thaliana pollen expressing the SCRs that
correspond to the parental SRKs used in chimera construction
(Supplemental Data; Figure S1). In this expression system,
AtS1pr::AleSRKa:AlSRKb and AtS1pr::AleSRK16:AlSRKb
(Figure 1A) confer Sa and S16 specificity, respectively: trans-
genic stigmas expressing these chimeras inhibit transgenic
A. thaliana AlSCRa- and AlSCR16-expressing pollen, respec-
tively, but not wild-type or AlSCRb-expressing pollen (N.A.B.,
K.G.D., P. Shah, A.A. McCulloch, M.E.N., and J.B.N., unpub-
lished data).
We constructed 11 AtS1pr::eSRKx(y)x:AlSRKb chimeras
(hereafter ‘‘eSRK chimeras’’) (Tables 1 and 2; Figure S2) using
AleSRKa, AleSRKb, and AleSRK16 (which arew62% similar),
AleSRK25 (which is 82% similar to AleSRK16; N.A.B., K.G.D.,
P. Shah, A.A. McCulloch, M.E.N., and J.B.N., unpublished
data), andCapsella grandifloraCgeSRK7 (which is 77% similar
to AleSRKa [23]). Pollination assays of stigmas from several
independent primary (T1) transformants using pollen that
expresses SCR corresponding to the hvI–hvIII region of
eSRK chimeras revealed that seven chimeras (Table 2; Fig-
ure S2B) failed to confer an incompatibility response, possibly
due to the disruptive steric effect of combining diverged eSRK
segments. However, the eSRK16(b)16:SRKb, eSRK16(25)16:
SRKb, eSRKa(7)a:SRKb, and eSRKa(b)b:SRKb chimeras
(Figure 1B; Figure S2A) were functional and each conferred
the SI specificity of the SRK allele from which the hvI–hvIII
region was derived (Table 1), as determined by pollination
assays in T1 and T2 transgenic progenies (Figure 1C). Thus,
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SRK Genes
(A) The AtS1pr::eSRKx:AlSRKb genes used for
construction of eSRK chimeras. The top diagram
shows the structure of a generic AtS1pr::eSRKx:
AlSRKb gene, in which the AtS1 promoter
(checkered arrowhead) drives an SRK transcrip-
tional unit with its seven exons and native
30 untranslated sequences. Exon 1 encodes the
SRKextracellular domain (eSRK), exon 2 encodes
the transmembrane domain (TM), and exons 3–7
encode the kinase domain. The unique SacI
restriction site used for construction of chimeras
is shown toward the 30 end of the eSRK. AlSRKb
sequences are shown in dark gray and eSRK
sequences (from the initiating methionine codon
to the unique SacI site) derived from other vari-
ants are shown in light gray. Due to the use of
the SacI site, all constructs used in this study
contain a common 23 amino acid region derived
from AlSRKb (shown in dark gray, spanning the
last 23 amino acids of eSRK, i.e., residues
411–434 in SRKb). The middle diagram is a magni-
fied view of the eSRK (with numbers indicating
amino acids). The vertical lines delineate pre-
dicted structural subdomains in the eSRK [27]:
SP, signal peptide; LLD1 and LLD2, lectin-like
domains 1 and 2; EGF-like, epidermal growth
factor-like domain; and PAN_APPLE domain.
The locations of hypervariable regions are indi-
cated below the diagrams and correspond to
the following amino acid segments in AlSRKb:
204–219 (hvI), 269–304 (hvII), 326–340 (hvIII). The
lower diagrams show the eSRKs of AtS1pr::
AleSRKa:AlSRKbandAtS1pr::AleSRK16:AlSRKb,
two of the constructs used for domain swaps.
(B) The structures of four functional chimeric
eSRKs are shown. The derivation of various
segments is shown by different colors or patterns:
AleSRKb, dark gray; AleSRKa, white; AleSRK16,
light gray; AleSRK25, stippled; CgeSRK7, slanted
bricks. The limits of the swapped region in these
and other chimeras analyzed are indicated in
Table 1 and their sequences are shown in
Figure S2.
(C) Pollination phenotypes of A. thaliana plants
transformed with eSRK chimeras. First- and
second-generation transgenic plants expressing
each chimera were pollinated using plants ex-
pressing the cognate SCR, other SCRs, and
wild-type pollen. eSRK chimeras are indicated
in the column below the female symbol:
a(b)b,AleSRKa(b)b:AlSRKb; 16(b)16,AleSRK16(b)
16:AlSRKb; a(7)a, CgeSRKa(7)a:AlSRKb; 16(25)16,AleSRK16(25)16:AlSRKb. The SCR variants expressed in pollen used for pollination assays are indicated in
the row to the right of the male symbol and correspond to the constructs shown in Figure S1: a, native AlSCRa; 25, native AlSCR25; 7, AlSCRb:CgSCR7; 16,
AlSCRb:AlSCR16; b, native AlSCRb. The numbers in parentheses show the number of T1 plants that expressed an incompatibility response toward pollen
expressing cognate SCR over the total number of primary transformants analyzed. 0 = an incompatible response (typically < 5 pollen tubes per pollinated
stigma); +++ = a compatible response (typically > 50 pollen tubes per pollinated stigma). For each construct, although the majority of transformants exhibiting
SI expressed a strong SI response (<5 pollen tubes per pollinated stigma), typically one or two transformants exhibited a weaker SI response (5–10 pollen tubes
per pollinated stigma).residues within the w160 amino acid segment spanning the
hvI–hvIII region of eSRK are sufficient for determining SI spec-
ificity in transgenic Arabidopsis.
SRK Residues Required for Ligand-Specific Activation
of the Incompatibility Response
To identify residues within the hvI–hvIII region that determine
SI specificity, we focused on the S7- and S25-determining
regions of eSRKa(7)a and eSRK16(25)16 (Table 1). The
eSRKa(7)a and eSRK16(25)16 chimeras were modified by
site-directed mutagenesis (Supplemental Data) to generatea series of mutants containing single-site substitutions at
each of the 42 polymorphic sites that differ between the hvI–
hvIII regions of eSRKa and eSRK7, and 44 out of the 46 poly-
morphic sites that differ between the hvI–hvIII regions of
eSRK16 and eSRK25 (Figure 2A). Each of the resulting
eSRKa(7)a and eSRK16(25)16 mutants had the chimeric
eSRK sequence except for one amino acid residue within the
hvI–hvIII region that was replaced with the residue found at
the corresponding position in eSRKa or eSRK16, respectively
(Figure 2A). The stigmas of T1 plants transformed with each of
the 42 eSRKa(7)a and 44 eSRK16(25)16 mutants were
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Functional Chimeras Observed Specificitya
Swapped Region
(SRKa #s)b
Number of Polymorphic Sites
within the Swapped Regionc
Numbers of Polymorphic Sites
outside the Swapped Regionc
eSRKa(b)b b 198–403 (197–403) 91 67
eSRK16(b)16 b 198–357 (197–357) 70 91
eSRKa(7)ad 7 196–351 (200–356) 42 58
eSRK16(25)16 25 197–355 (198–357) 46 28
a SI specificity was determined by pollinating the stigmas of transgenic plants expressing each chimera with pollen expressing the SCR variant correspond-
ing to the swapped hvI–hvIII region. The source of pollen was A. thaliana plants transformed with one of the SCR constructs diagrammed in Figure S1.
b The numbers show the limits of the swapped region in each eSRK chimera (see alignments in Figure S2), with the corresponding numbers in SRKa shown
in parentheses for reference.
c The numbers indicate the number of amino acid differences between the pair of SRK variants used to generate each chimera.
d The eSRKa(7)a chimera contains the smallest swapped region of all chimeras tested.pollinated with A. thaliana SCR7- and SCR25-expressing
pollen (Figure S3), respectively. In all, 35 eSRKa(7)a mutants
and 38 eSRK16(25)16 mutants (Figure 2A) conferred a strong
incompatibility response in at least some of the T1 transform-
ants analyzed, indicating that the mutant chimeras retained
the specificity of the ‘‘wild-type’’ eSRKa(7)a or eSRK16(25)16
chimeras and that residues that were replaced in these
mutants are not required for S7 or S25 specificity.
For the remaining mutants (Figure 2A), none of the 10–18
independent T1 transformants analyzed per construct
conferred a strong incompatibility response toward pollen ex-
pressing the SCR corresponding to the swapped specificity-
determining region, indicating that the substituted residues
are important for the S7 or S25 specificity to be manifested.
The majority of these mutant eSRKa(7)a and eSRK16(25)16
chimeras produced only plants whose stigmas were fully
compatible with SCR7- and SCR25-expressing pollen, respec-
tively. However, chimeras carrying the L218V substitution in
eSRKa(7)a and the Q285E substitution in eSRK16(25)16
conferred a weakened incompatibility phenotype (Figure S3),
characterized by variable expressivity of the response or
a degree of leakiness that allowed the germination of some
SCR7- or SCR25-expressing pollen grains. This partial disrup-
tion of SRK function might be due to the partial insensitivity of
the sites to volume- (L218V) or charge- (Q285E) changing
substitutions.
To determine whether the identified essential sites are not
only necessary for eSRKa(7)a:SRKb and eSRK16(25)16:SRKb
function but also sufficient for S7 or S25 specificity, we gener-
ated a construct that combined substitutions at the seven sites
essential for eSRKa(7)a function into the eSRKa backbone,
Table 2. eSRK Chimeras that Were Nonfunctional In Planta
Nonfunctional
Chimeras
Expected
Specificitya
Swapped
region (SRKa #s)b
Number of Transgenic
Plants Analyzed
eSRKa(b)a b 198–357 (197–357) 7
eSRK25(16)25 16 197–355 (198–357) 16
eSRK25(16)16 16 197–401 (198–403) 17
eSRKa(16)a 16 197–354 (198–356) 8
eSRKb(16)b 16 196–355 (197–357) 12
eSRK25(a)25 a 198–357 (198–357) 13
eSRK16(a)16 a 198–356 (198–356) 8
a SI specificity was assessed by pollinating the stigmas of transgenic plants
expressing each chimera with A. thaliana pollen expressing the SCR variant
corresponding to the swapped hvI–hvIII region. For each chimera, the indi-
cated specificity was expected but not conferred in transgenic stigmas.
b The numbers show the limits of the swapped region in each eSRK chimera
(see alignments in Figure S2), with the corresponding numbers in SRKa
shown in parentheses for reference.and another construct that combined substitutions at the six
sites essential for eSRK16(25)16 function into the eSRK16
backbone. However, neither of these two multiple-substitution
mutants conferred an incompatibility response in transgenic
stigmas pollinated with SCR7- or SCR25-expressing pollen.
To exclude the possibility that the nonfunctionality of
mutant eSRK chimeras is due to their suboptimal accumula-
tion in stigmas, we tagged the original wild-type eSRKa(7)a
and eSRK16(25)16 chimeras, and their mutant derivatives,
by inserting a hemagglutinin (HA) tag at the N terminus of
mature eSRK (Supplemental Data). The HA-eSRK16(25)16
chimeras, including the wild-type chimera, were not func-
tional, likely due to disruptive effects of the HA tag, and
were not investigated further. In contrast, the HA-eSRKa(7)a
chimeras recapitulated the pollination phenotypes observed
with their nontagged counterparts. Importantly, for all
nonfunctional HA-eSRKa(7)a chimeras, T1 transformants
were obtained whose stigmas accumulated SRK to levels
equivalent to, or higher than, those of wild-type HA-eSRKa(7)a
in stigmas that expressed S7 specificity (Figure 2B). Thus, the
nonfunctionality of chimeras containing substitutions at
essential sites cannot be explained by reduced SRK levels in
transgenic stigmas. Therefore, amino acids at essential sites
most likely function as specificity-determining residues.
However, the failure of multiple-substitution eSRKa(7)a and
eSRK16(25)16 mutants to confer an incompatibility response
suggests that additional residues in the hI–hvIII region might
also be required for SRK specificity. Such residues might
have escaped detection because a single amino acid substitu-
tion at these sites might not produce a detectable effect on
SRK function.
Nevertheless, the observation that the majority of substitu-
tions (even those that changed charge, volume, or polarity)
were not disruptive, indicates that the specific amino acids
occupying most polymorphic sites in the hvI–hvIII region are
not critical for function. Interestingly, the few sites found to
be essential for eSRKa(7)a and eSRK16(25)16 function are
clustered in two noncontiguous regions located at equivalent
positions in the hvI and hvII regions of the two chimeras, and
two of these sites were found to be essential for the function
of both chimeras.
Prediction of Functionally Important Amino Acid Residues
in Other SRK Variants
To determine whether the amino acid sites we identified as
likely specificity determinants in CgSRK7 or AlSRK25 might
also determine specificity in other SRK variants, we performed
pairwise alignments of the hvI–hvIII region for 34 intraspecific
or interspecific pairs of the most closely related eSRK variants
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789Figure 2. Structure and Immunoblot Analysis of
eSRKa(7)a:SRKb and eSRK16(25)16:SRKb
Substitution Mutants
(A) Single-codon substitutions in eSRK chimeras.
The diagrams show the specificity-determining
hvI–hvIII regions of the eSRKa(7)a and
eSRK16(25)16 chimeras, with amino acid resi-
dues depicted by vertical bars. The bottom
diagram shows the location of the LLD2 and
EGF-like domains and hypervariable regions
hvI, hvII, and hvIII. Residues that do not differ
between eSRKa and eSRKa(7)a or between
eSRK16 and eSRK16(25)16 are shown by light
gray bars. Polymorphic residues that were modi-
fied by substitution mutagenesis are shown by
dark gray and black bars. Each of these variable
residues, with the exception of 2 residues in
eSRK16(25)16 (marked by gray circles, mutants
of which failed to generate transgenic plants),
were individually replaced in eSRKa(7)a with resi-
dues found at the equivalent positions in eSRKa,
and in eSRK16(25)16 with residues found at the
equivalent positions in eSRK16. Transgenic
stigmas expressing each of the single-codon
substitution eSRKa(7)a or eSRK16(25)16 deriva-
tives were tested by pollination with SCR7- or
SCR25-expressing pollen, respectively. For
most substitution mutants (substituted residues
shown as dark gray bars), the stigmas of at least some transformants [13%–88% of transformants for eSRKa(7)a mutants and 12%–71% of transformants
for eSRK16(25)16 mutants] exhibited an incompatible response. For each of the substitution mutants that failed to confer an incompatibility response,
between 10 and 18 independent transformants were assayed. Amino acid residues found to be required for the function of eSRK chimeras are shown
by black bars with arrows indicating the amino acid substitution that caused loss of chimera function. The L218V substitution in eSRKa(7)a and the
Q285E substitution in eSRK16(25)16 conferred a weakened incompatibility response (Figure S3). The X298A change in eSRKa(7)a involved inserting alanine
at amino acid site 298. Note that substitutions at two sites, 213 and 301, disrupted the function of both eSRKa(7)a and eSRK16(25)16 chimeras: site 213 was
sensitive to a change from the polar and charged lysine to a nonpolar and uncharged methionine or phenylalanine, whereas site 301 was sensitive to
changes in volume.
(B) Immunoblot analysis of eSRK chimeras. For immunoblot analysis of hemagglutinin (HA)-tagged eSRKa(7)a chimeras, proteins were extracted from
the stigmas of plants transformed with AtS1pr::eSRKa(7)a:AlSRKb (wt) and its single- and multiple-codon substitution derivatives, and subjected to protein
immunoblot analysis (Supplemental Data). The ‘‘wt’’ lane shows the level of nonmutated wild-type eSRKa(7)a protein found in stigmas exhibiting an incom-
patibility response toward SCR7-expressing pollen. The remaining lanes show representative patterns for eSRKa(7)a substitution derivatives: nine single-
codon substitution derivatives labeled according to the amino acid substitution introduced into each chimera (numbering as in [A]), and a multiple-codon
substitution derivative (multiple). The dashed box indicates the substitution derivatives that did not confer an incompatible response toward SCR7-express-
ing pollen. The blot was probed sequentially with an anti-HA monoclonal antibody (top panel) and an antiactin antibody as loading control (bottom panel). The
arrow indicates the full-length eSRKa(7)a:SRKb receptor and the asterisk indicates the alternative smaller SRK products typically produced in stigmas [37].that are known or assumed to encode different SI specificities
(Figure S4). We reasoned that this strategy is preferable to
comparing highly diverged SRK sequences, which can impede
the prediction of specificity-determining residues because of
overall high variability in eSRKs [20]. Alignment of pairwise
consensus sequences (Figure 3, Figure S4) showed that
none of the 11 essential sites identified in planta was polymor-
phic in all sequences. However, seven of these sites were poly-
morphic in more than 50% of the comparisons, and the two
sites found to be essential for both CgSRK7 and AlSRK25
were polymorphic in more than 60% of the comparisons
(Figure 3). Additionally, several of the 15 sites in hvI and hvII
that exhibited polymorphisms in more than 50% of pairwise
comparisons coincided with, or clustered near, the function-
ally important residues identified in planta (Figure 3).
Conclusions
Our results provide the first empirical support for the hypoth-
esis suggested by previous comparisons of SRK sequences
[24, 25], that SCR-specific activation of SRK is a function of
hvI and hvII (which are conserved in functionally equivalent
SRKs) rather than hvIII (which differs by many substitutions
between functionally equivalent SRKs). Although theory
predicts high diversity at amino acids that are closely linked
to sites subject to balancing selection [26], the finding thatso very few of the residues previously shown to bear signals
of positive selection (and therefore presumed to function as
specificity determinants) are essential for SRK function
(Figure 3) was unexpected. Although some ‘‘positively
selected’’ sites that lie outside the hvI, hvII, and hvIII regions
[21, 24] might be important for receptor functions unrelated
to ligand recognition (e.g., see [27]), polymorphisms at many
positively selected sites within the hvI–hvIII region of eSRK
might have little functional importance. Rather, they might
exhibit false signals of positive selection, as shown for ‘‘rapidly
evolving’’ regions in the human genome, in which positively
selected polymorphisms were found to result, not from selec-
tion but from biased gene conversion [28–30]. Our finding that
17 out of 24 positively selected sites in eSRK (Figure S4) can be
replaced with other amino acids with no consequence for
receptor function and ligand selectivity, together with the
documented occurrence of gene conversion at the SRK gene
[19, 31], suggests that a nonselective process might similarly
drive accumulation of polymorphisms in eSRK.
We propose that for many if not all SRK variants, SI speci-
ficity is determined primarily by small amino acid regions
located toward the C-terminal end of hvI and C-terminal half
of hvII. We further suggest that it is the overall sequence or
3D conformation of these small segments, rather than indi-
vidual residues within them, that determines SI specificity.
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The eSRK sequences from A. lyrata, A. halleri, C. grandiflora, Brassica oleracea, B. rapa, and Raphanus sativus were analyzed by pairwise alignment of the
most closely related sequences that are either known or likely to encode different SI specificities (Figure S4). Pairwise consensus sequences were generated
and aligned (Figure S4), and the percentage of consensus sequences that differed at a particular site was calculated. Each site was assigned a ‘‘substitution
score’’ between 0 and 100, as shown on the y axis: a score of ‘‘0’’ indicates that 0% of the variant pairs differ at that site, and a score of ‘‘100’’ indicates that
100% of the pairs differ at that site. The x axis indicates amino acid site number along the hvI–hvIII region after removal of indels (Figure S4); this numbering
was used to highlight the overlap and clustering of highly variable residues relative to the essential residues identified in planta. The short dark bars indicate
the number of sequence pairs with substitutions for each site. Asterisks and circles indicate the residues found to be essential for the function of the
eSRK16(25)16 and eSRKa(7)a chimeras, respectively. The locations of the essential sites using eSRKa as a reference sequence (Figure 2) are: K213,
I217, L218, P294, X298, D300, and Y301 in eSRK7, and K213, Q285, M289, S292, H295, and V301 in eSRK25. Note that the hvI and hvII regions, and in partic-
ular clusters of sites in the vicinity of the essential residues identified in planta, are enriched for residues showing elevated variability relative to other
segments, as indicated by the number of residues that are polymorphic in more than 50% of the pairwise alignments. Substitution scores for the essential
sites identified in vivo are significantly different from the nonessential sites (see Figure S4).The fact that residues in two discrete regions underlie SRK
specificity is not surprising, as similar results were obtained
for other recognition molecules [32–36]. It is tempting to spec-
ulate that the essential eSRK residues identified in this study,
or the two clusters that encompass them, might be surface-
exposed regions that are brought into close proximity in
a three-dimensional structure to form part of an SCR-binding
pocket. A high-resolution three-dimensional structure of the
eSRK in its ligand-bound and unbound forms is required to
address this issue. Nevertheless, three-dimensional models
of eSRK subdomains predict with confidence that hvI is
a solvent-exposed segment of the LLD2 domain [27]. Accord-
ingly, it is not surprising that the charge-, polarity-, or volume-
changing substitutions (Figure S3) that were introduced at
essential residues in this region would be disruptive. In
contrast, the resolution of the hvII region, which maps to the
structurally distinct LLD2 and EGF-like domains, is less clear
[27], and it is difficult to surmise how substitutions in this
region might impact SRK structure and function. Future
in vivo structure-function analyses of other SRK variants,
together with high-resolution structural studies, will undoubt-
edly elucidate the contribution of essential eSRK residues to
ligand binding, and help explain how large numbers of SRK
and SCR variants have coevolved to maintain their highly
specific interaction.
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Supplemental Data include four figures and Supplemental Experimental
Procedures and can be found with this article online at http://www.cell.
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